View More

CUREXO Signs Sales Agreement with Meril

Curexo signed a contract with Meril Healthcare in India to sell at least 53 CUVIS-joint surgical robots by the end of 2025.CUVIS-joint is designed to cut bone, allowing precise implant insertion. It enables patient-specific procedures based on CT images and is equipped with AI Auto Segmentation as well as a guide on choice of implant size and location to cut bones.The company is pursuing an open platform solution compatible with a variety of implants in Korea and abroad."As India is also suffering from ongoing COVID-19 pandemic, we are planning to support sales activities of Meril Healthcare via online training for doctors and local workers in operations after the first export to India. Through this solution, we believe CUVIS-joint's instructions are easy to learn and many functions will help them," a CUREXO official said.In addition, CUVIS-joint is preparing for CE Mark approval in Europe and FDA 510(k) clearance by 1H21. The company submitted the device for FDA 510(k) clearance for the CUVIS-spine robot last month.By Julie A. Vetalicehttps://www.orthoworld.com/curexo-gains-ce-mark-approval-for-cuvis-spine-robot/

View More

CUREXO Gains CE Mark Approval for CUVIS-spine Robot

Curexo received approval under the CE Mark for the CUVIS-spine surgical robot. The company is also planning to apply for FDA clearance.CUVIS-spine guides and supports the pedicle screw to the correct position using a robotic arm, one-step surgical tools and a real-time location sensor. Real-time patient position monitoring can correct the surgical plan in real time, and can help reduce radiation exposure for the patient and O.R. staff.CUVIS-spine provides imaging compatibility on not only C-arms, but also O-arms. The device received approval by Korea's Ministry of Food and Drug Safety and launched late last year in the region.The company is also developing CUVIS-joint for potential launch in 2020.According to the CEO of CUREXO, "Certifying the CE certificate for CUVIS-spine is another big step taken after last year's MFDS certificate. Also, achieving the CE certificate for the CUVIS-spine is meaningful because now CUREXO is aiming for the global market with a self-developed surgical robot. The following task will be FDA approval and entering the U.S. market, which is number one in surgical robots.By Julie A. Vetalicehttps://www.orthoworld.com/curexo-gains-ce-mark-approval-for-cuvis-spine-robot/

View More

CUREXO Launches Robot-Assisted Spine Surgery Device

Curexo launched the CUVIS-spine robot-assisted spine surgery device following approval by Korea's Ministry of Food and Drug Safety.CUVIS-spine guides and supports the pedicle screw to the correct position using a robotic arm, one-step surgical tool and real-time location sensor. Real-time patient position monitoring can correct the surgical plan in real time, and can help reduce radiation exposure for the patient and O.R. staff.Curexo seeks to establish an overseas sales agency, as it expects to receive CE Mark approval in 1H20 and will also apply for FDA clearance.The company is also developing CUVIS-joint for launch in 2020.By Julie A. VetaliceSource: https://www.orthoworld.com/curexo-launches-robot-assisted-spine-surgery-device/